Fehr Gordon J. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Apr 16, 2013
Insider Transaction Report
Form 4
Fehr Gordon J.
Director
Transactions
- Exercise/Conversion
Common Stock
2013-04-15$2.19/sh+15,000$32,850→ 205,143 total - Sale
Common Stock
2013-04-15$6.04/sh−15,000$90,645→ 190,143 total - Exercise/Conversion
Stock Option (right to buy)
2013-04-15−15,000→ 0 totalExercise: $2.19Exp: 2013-05-08→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]This option is fully vested.